Bethe G, Nau R, Wellmer A, Hakenbeck R, Reinert R R, Heinz H P, Zysk G
Department of Medical Microbiology and Virology, University of Düsseldorf, Geb. 22.21/U1, Universitätsstrasse 1, D-40225 Düsseldorf, Germany.
FEMS Microbiol Lett. 2001 Nov 27;205(1):99-104. doi: 10.1111/j.1574-6968.2001.tb10931.x.
The surface-associated subtilisin-like serine protease PrtA was identified by screening a genomic expression library from Streptococcus pneumoniae using a convalescent-phase serum. In Western blot analysis two forms of PrtA were detected in whole cell lysate and a truncated form only in culture supernatant suggesting that PrtA is produced as a precursor protein, translocated to the cell surface, truncated, and released into the surroundings. A 5' fragment of the gene was found highly conserved among 78 pneumococcal isolates of clinical relevance. Immunogenicity of PrtA, limited genetic variation, and the involvement in pneumococcal virulence demonstrated in in vivo experiments might identify PrtA as a promising candidate for a protein based vaccine.
通过使用恢复期血清筛选肺炎链球菌的基因组表达文库,鉴定出了与表面相关的枯草杆菌蛋白酶样丝氨酸蛋白酶PrtA。在蛋白质印迹分析中,在全细胞裂解物中检测到两种形式的PrtA,而在培养上清液中仅检测到一种截短形式,这表明PrtA作为前体蛋白产生,转运至细胞表面,被截短,然后释放到周围环境中。发现该基因的5'片段在78株具有临床相关性的肺炎球菌分离株中高度保守。体内实验证明了PrtA的免疫原性、有限的遗传变异以及参与肺炎球菌毒力,这可能表明PrtA是基于蛋白质的疫苗的有前景的候选物。